Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Ubiquitylation

Recombinant Human USP35 protein (ab127080)

Description:
Application:
SDS-PAGE
Reactivity:
Conjugate:

(+)-JQ1, BET bromodomain inhibitor (ab141498)

Description:
Potent, selective and cell-permeable BET bromodomain inhibitor
Application:
Reactivity:
Conjugate:

Human BRCA1 knockout A549 cell line (ab276099)

Description:
Human BRCA1 knockout A549 cell line
Application:
Reactivity:
Conjugate:

Human KEAP1 knockout HeLa cell lysate (ab263776)

Description:
Human KEAP1 knockout HeLa cell lysate
Application:
Reactivity:
Conjugate:

NSC-687852, USP14 and UCHL5 inhibitor (ab142195)

Description:
Cell-permeable USP14 and UCHL5 inhibitor. Apoptotic agent.
Application:
Reactivity:
Conjugate:

PYR-41, Ubiquitin-activating enzyme (E1) inhibitor (ab141469)

Description:
Ubiquitin-activating enzyme (E1) inhibitor
Application:
Reactivity:
Conjugate:

Spautin-1, USP10 and USP13 inhibitor (ab142205)

Description:
Cell-permeable USP10 and USP13 inhibitor
Application:
Reactivity:
Conjugate:

TAME hydrochloride, Ubiquitin ligase APC/C inhibitor (ab141493)

Description:
Competitive ubiquitin ligase APC/C inhibitor.
Application:
Reactivity:
Conjugate:
  • ‹
  • 1
  • 2
  • ...
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • ›
Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.